XML 76 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Non-Guarantor Subsidiary Financial Information Level 4 (Details) - Consolidating Statement of Cash Flows (USD $)
In Millions, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Net Cash Provided by (Used in) Operating Activities $ (23) $ 21
Cash flows provided by (used in) investing activities    
Capital expenditures (96) (92)
Proceeds from the sale of (purchases of) debt securities, net (1) 2
Capitalized interest (1) 0
Proceeds from sale of assets 1 10
Capital contribution to subsidiary 0 0
Return of capital from subsidiary from sales of accounts receivable 0 0
Change in restricted cash 4 0
Funds remitted to unconsolidated affiliates (13) (1)
Net cash (used in) provided by investing activities (106) (81)
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 16 (7)
Borrowings of long-term debt 1,128 451
Repayments of long-term debt (1,045) (479)
Repayment of advance from affiliates 0 (7)
Net Intercompany Loan Borrowings (Repayments) 0 0
Long-term debt and credit facility financing fees (37) (13)
Capital contribution from parent 0 16
Common stock dividends paid 0 (2)
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities 62 (41)
Effect of exchange rates on cash and cash equivalents (2) 4
Decrease in cash and cash equivalents (69) (97)
Cash and cash equivalents (unrestricted) at beginning of period 401 416
Cash and cash equivalents (unrestricted) at end of period 332 319
Momentive Specialty Chemicals Inc. [Member]
   
Net Cash Provided by (Used in) Operating Activities (33) (5)
Cash flows provided by (used in) investing activities    
Capital expenditures (49) (39)
Proceeds from the sale of (purchases of) debt securities, net 0 0
Capitalized interest 0  
Proceeds from sale of assets 0 9
Capital contribution to subsidiary (15) (15)
Return of capital from subsidiary from sales of accounts receivable 126 65
Change in restricted cash 0  
Funds remitted to unconsolidated affiliates 0 0
Net cash (used in) provided by investing activities 62 20
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 0
Borrowings of long-term debt 0 0
Repayments of long-term debt (545) (276)
Repayment of advance from affiliates   (7)
Net Intercompany Loan Borrowings (Repayments) 437 258
Long-term debt and credit facility financing fees (13) (2)
Capital contribution from parent 0 16
Common stock dividends paid 0 (2)
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities (121) (13)
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents (92) 2
Cash and cash equivalents (unrestricted) at beginning of period 276 212
Cash and cash equivalents (unrestricted) at end of period 184 214
Subsidiary Issuers [Member]
   
Net Cash Provided by (Used in) Operating Activities 1 (66)
Cash flows provided by (used in) investing activities    
Capital expenditures 0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0
Capitalized interest 0  
Proceeds from sale of assets 0 0
Capital contribution to subsidiary 0 0
Return of capital from subsidiary from sales of accounts receivable 0 0
Change in restricted cash 0  
Funds remitted to unconsolidated affiliates 0 0
Net cash (used in) provided by investing activities 0 0
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 0
Borrowings of long-term debt 1,108 450
Repayments of long-term debt (120) 0
Repayment of advance from affiliates   0
Net Intercompany Loan Borrowings (Repayments) (882) (364)
Long-term debt and credit facility financing fees (24) (11)
Capital contribution from parent 0 0
Common stock dividends paid (83) (9)
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities (1) 66
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0
Combined Subsidiary Guarantors [Member]
   
Net Cash Provided by (Used in) Operating Activities 17 16
Cash flows provided by (used in) investing activities    
Capital expenditures 0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0
Capitalized interest 0  
Proceeds from sale of assets 0 0
Capital contribution to subsidiary (10) (10)
Return of capital from subsidiary from sales of accounts receivable 0 0
Change in restricted cash 0  
Funds remitted to unconsolidated affiliates 0 0
Net cash (used in) provided by investing activities (10) (10)
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 0
Borrowings of long-term debt 0 0
Repayments of long-term debt 0 0
Repayment of advance from affiliates   0
Net Intercompany Loan Borrowings (Repayments) (2) (3)
Long-term debt and credit facility financing fees 0 0
Capital contribution from parent 10 10
Common stock dividends paid (15) (13)
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities (7) (6)
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0
Combined Non-Guarantor Subsidiaries [Member]
   
Net Cash Provided by (Used in) Operating Activities 90 98
Cash flows provided by (used in) investing activities    
Capital expenditures (47) (53)
Proceeds from the sale of (purchases of) debt securities, net (1) 2
Capitalized interest (1)  
Proceeds from sale of assets 1 1
Capital contribution to subsidiary 0 0
Return of capital from subsidiary from sales of accounts receivable 0 0
Change in restricted cash 4  
Funds remitted to unconsolidated affiliates (13) (1)
Net cash (used in) provided by investing activities (57) (51)
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 16 (7)
Borrowings of long-term debt 20 1
Repayments of long-term debt (380) (203)
Repayment of advance from affiliates   0
Net Intercompany Loan Borrowings (Repayments) 447 109
Long-term debt and credit facility financing fees 0 0
Capital contribution from parent 15 15
Common stock dividends paid 0 0
Return of capital to parent from sales of accounts receivable (126) (65)
Net cash used in financing activities (8) (150)
Effect of exchange rates on cash and cash equivalents (2) 4
Decrease in cash and cash equivalents 23 (99)
Cash and cash equivalents (unrestricted) at beginning of period 125 204
Cash and cash equivalents (unrestricted) at end of period 148 105
Eliminations [Member]
   
Net Cash Provided by (Used in) Operating Activities (98) (22)
Cash flows provided by (used in) investing activities    
Capital expenditures 0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0
Capitalized interest 0  
Proceeds from sale of assets 0 0
Capital contribution to subsidiary 25 25
Return of capital from subsidiary from sales of accounts receivable (126) (65)
Change in restricted cash 0  
Funds remitted to unconsolidated affiliates 0 0
Net cash (used in) provided by investing activities (101) (40)
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 0
Borrowings of long-term debt 0 0
Repayments of long-term debt 0 0
Repayment of advance from affiliates   0
Net Intercompany Loan Borrowings (Repayments) 0 0
Long-term debt and credit facility financing fees 0 0
Capital contribution from parent (25) (25)
Common stock dividends paid 98 22
Return of capital to parent from sales of accounts receivable 126 65
Net cash used in financing activities 199 62
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0
Cash and cash equivalents (unrestricted) at end of period $ 0 $ 0